Clinical trial
A Multicentre, Double-Blind, Randomized Placebo-Controlled Study of 70mg Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients
NCT00157690 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicentre, Double-Blind, Randomized Placebo-Controlled Study of 70mg Alendronate Once Weekly for the Prevention and Treatment of Osteoporosis in Canadian Adult Cystic Fibrosis Patients
- Lead sponsor
- McMaster University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- August 31, 2006
- Enrollment
- 56 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.